PBE
Invesco Biotechnology & Genome ETF
$95.95+0.26 (+0.27%)Close Nov 18, 2026
Loading the growth chart…
Growth of $10,000
Jun 23, 2005 – Nov 18, 2026, Dividends reinvested
- Final balance
- $68,811
- CAGR
- +9.43%
- Max drawdown
- −45.69%
Trailing returns (%)
PBE's average annual return was 8.68% over the last 10 years and 8.71% over the last 20 years, through Nov 18, 2026. $10,000 in PBE on Nov 18, 2016 grew to $22,987 by Nov 18, 2026, with dividends reinvested.
Total
- 1M
- −0.14%
- 3M
- +0.72%
- 6M
- +20.53%
- YTD
- +18.08%
- 1Y
- +24.80%
Per year
- 3Y
- +20.36%
- 5Y
- +6.06%
- 10Y
- +8.68%
- 15Y
- +11.97%
- 20Y
- +8.71%
- Since 2005
- +9.43%
Annual returns
2005 from Jun 23 · 2026 through Nov 18
PBE returns by year
| Year | Return |
|---|---|
| 2026 through Nov 18 | +18.08% |
| 2025 | +24.84% |
| 2024 | +1.10% |
| 2023 | +3.71% |
| 2022 | −10.83% |
| 2021 | +1.54% |
| 2020 | +25.66% |
| 2019 | +18.65% |
| 2018 | −0.19% |
| 2017 | +22.28% |
| 2016 | −22.90% |
| 2015 | +1.72% |
Metrics
Since 2005| Volatility | 25.22% |
|---|---|
| Sharpe ratio | 0.48 |
| Sortino ratio | 0.69 |
| Calmar ratio | 0.21 |
| Longest drawdown | 5 years |
Worst drawdowns
Since 2005| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −45.7% | Oct 2007 | Mar 2009 | Oct 2010 | 3 years |
| −44.6% | Jul 2015 | Jun 2016 | Jul 2020 | 5 years |
| −37.8% | Feb 2021 | Jun 2022 | Nov 2025 | 4.8 years |
| −26.4% | May 2011 | Aug 2011 | Jul 2012 | 1.1 years |
| −21.1% | Feb 2006 | Jul 2006 | Apr 2007 | 1.1 years |